Cargando…

Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities

The p-traps of hospital handwashing sinks represent a potential reservoir for antimicrobial-resistant organisms of major public health concern, such as carbapenemase-producing KPC+ Klebsiella pneumoniae (CPKP). Bacteriophages have reemerged as potential biocontrol agents, particularly against biofil...

Descripción completa

Detalles Bibliográficos
Autores principales: Santiago, Ariel J., Burgos-Garay, Maria L., Kartforosh, Leila, Mazher, Mustafa, Donlan, Rodney M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIMS Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099197/
https://www.ncbi.nlm.nih.gov/pubmed/32226914
http://dx.doi.org/10.3934/microbiol.2020003
_version_ 1783511299512074240
author Santiago, Ariel J.
Burgos-Garay, Maria L.
Kartforosh, Leila
Mazher, Mustafa
Donlan, Rodney M.
author_facet Santiago, Ariel J.
Burgos-Garay, Maria L.
Kartforosh, Leila
Mazher, Mustafa
Donlan, Rodney M.
author_sort Santiago, Ariel J.
collection PubMed
description The p-traps of hospital handwashing sinks represent a potential reservoir for antimicrobial-resistant organisms of major public health concern, such as carbapenemase-producing KPC+ Klebsiella pneumoniae (CPKP). Bacteriophages have reemerged as potential biocontrol agents, particularly against biofilm-associated, drug-resistant microorganisms. The primary objective of our study was to formulate a phage cocktail capable of targeting a CPKP strain (CAV1016) at different stages of colonization within polymicrobial drinking water biofilms using a CDC biofilm reactor (CBR) p-trap model. A cocktail of four CAV1016 phages, all exhibiting depolymerase activity, were isolated from untreated wastewater using standard methods. Biofilms containing Pseudomonas aeruginosa, Micrococcus luteus, Stenotrophomonas maltophilia, Elizabethkingia anophelis, Cupriavidus metallidurans, and Methylobacterium fujisawaense were established in the CBR p-trap model for a period of 28 d. Subsequently, CAV1016 was inoculated into the p-trap model and monitored over a period of 21 d. Biofilms were treated for 2 h at either 25 °C or 37 °C with the phage cocktail (10(9) PFU/ml) at 7, 14, and 21 d post-inoculation. The effect of phage treatment on the viability of biofilm-associated CAV1016 was determined by plate count on m-Endo LES agar. Biofilm heterotrophic plate counts (HPC) were determined using R2A agar. Phage titers were determined by plaque assay. Phage treatment reduced biofilm-associated CAV1016 viability by 1 log(10) CFU/cm(2) (p < 0.05) at 7 and 14 d (37 °C) and 1.4 log(10) and 1.6 log(10) CFU/cm(2) (p < 0.05) at 7 and 14 d, respectively (25 °C). No significant reduction was observed at 21 d post-inoculation. Phage treatment had no significant effect on the biofilm HPCs (p > 0.05) at any time point or temperature. Supplementation with a non-ionic surfactant appears to enhance phage association within biofilms. The results of this study suggest the potential of phages to control CPKP and other carbapenemase-producing organisms associated with microbial biofilms in the healthcare environment.
format Online
Article
Text
id pubmed-7099197
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AIMS Press
record_format MEDLINE/PubMed
spelling pubmed-70991972020-03-27 Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities Santiago, Ariel J. Burgos-Garay, Maria L. Kartforosh, Leila Mazher, Mustafa Donlan, Rodney M. AIMS Microbiol Research Article The p-traps of hospital handwashing sinks represent a potential reservoir for antimicrobial-resistant organisms of major public health concern, such as carbapenemase-producing KPC+ Klebsiella pneumoniae (CPKP). Bacteriophages have reemerged as potential biocontrol agents, particularly against biofilm-associated, drug-resistant microorganisms. The primary objective of our study was to formulate a phage cocktail capable of targeting a CPKP strain (CAV1016) at different stages of colonization within polymicrobial drinking water biofilms using a CDC biofilm reactor (CBR) p-trap model. A cocktail of four CAV1016 phages, all exhibiting depolymerase activity, were isolated from untreated wastewater using standard methods. Biofilms containing Pseudomonas aeruginosa, Micrococcus luteus, Stenotrophomonas maltophilia, Elizabethkingia anophelis, Cupriavidus metallidurans, and Methylobacterium fujisawaense were established in the CBR p-trap model for a period of 28 d. Subsequently, CAV1016 was inoculated into the p-trap model and monitored over a period of 21 d. Biofilms were treated for 2 h at either 25 °C or 37 °C with the phage cocktail (10(9) PFU/ml) at 7, 14, and 21 d post-inoculation. The effect of phage treatment on the viability of biofilm-associated CAV1016 was determined by plate count on m-Endo LES agar. Biofilm heterotrophic plate counts (HPC) were determined using R2A agar. Phage titers were determined by plaque assay. Phage treatment reduced biofilm-associated CAV1016 viability by 1 log(10) CFU/cm(2) (p < 0.05) at 7 and 14 d (37 °C) and 1.4 log(10) and 1.6 log(10) CFU/cm(2) (p < 0.05) at 7 and 14 d, respectively (25 °C). No significant reduction was observed at 21 d post-inoculation. Phage treatment had no significant effect on the biofilm HPCs (p > 0.05) at any time point or temperature. Supplementation with a non-ionic surfactant appears to enhance phage association within biofilms. The results of this study suggest the potential of phages to control CPKP and other carbapenemase-producing organisms associated with microbial biofilms in the healthcare environment. AIMS Press 2020-02-26 /pmc/articles/PMC7099197/ /pubmed/32226914 http://dx.doi.org/10.3934/microbiol.2020003 Text en © 2020 the Author(s), licensee AIMS Press This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
spellingShingle Research Article
Santiago, Ariel J.
Burgos-Garay, Maria L.
Kartforosh, Leila
Mazher, Mustafa
Donlan, Rodney M.
Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities
title Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities
title_full Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities
title_fullStr Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities
title_full_unstemmed Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities
title_short Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities
title_sort bacteriophage treatment of carbapenemase-producing klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099197/
https://www.ncbi.nlm.nih.gov/pubmed/32226914
http://dx.doi.org/10.3934/microbiol.2020003
work_keys_str_mv AT santiagoarielj bacteriophagetreatmentofcarbapenemaseproducingklebsiellapneumoniaeinamultispeciesbiofilmapotentialbiocontrolstrategyforhealthcarefacilities
AT burgosgaraymarial bacteriophagetreatmentofcarbapenemaseproducingklebsiellapneumoniaeinamultispeciesbiofilmapotentialbiocontrolstrategyforhealthcarefacilities
AT kartforoshleila bacteriophagetreatmentofcarbapenemaseproducingklebsiellapneumoniaeinamultispeciesbiofilmapotentialbiocontrolstrategyforhealthcarefacilities
AT mazhermustafa bacteriophagetreatmentofcarbapenemaseproducingklebsiellapneumoniaeinamultispeciesbiofilmapotentialbiocontrolstrategyforhealthcarefacilities
AT donlanrodneym bacteriophagetreatmentofcarbapenemaseproducingklebsiellapneumoniaeinamultispeciesbiofilmapotentialbiocontrolstrategyforhealthcarefacilities